Derivatives of dolaproine-dolaisoleucine peptides
US11312748B2 · kind B2 · utility
0Cited by
11References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2019 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | Nov 14, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are peptide analogs, pharmaceutical compositions comprising such compounds, and methods of treating cancer with such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.